X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (647) 647
life sciences & biomedicine (638) 638
humans (600) 600
middle aged (434) 434
aged (407) 407
male (387) 387
female (383) 383
oncology (379) 379
hematology (376) 376
adult (370) 370
aged, 80 and over (278) 278
treatment outcome (218) 218
abridged index medicus (203) 203
prognosis (201) 201
leukemia (167) 167
adolescent (149) 149
myelodysplastic syndromes - drug therapy (136) 136
antineoplastic combined chemotherapy protocols - therapeutic use (134) 134
acute myeloid leukemia (122) 122
young adult (122) 122
leukemia, myeloid, acute - drug therapy (118) 118
myelodysplastic syndromes (118) 118
hematology, oncology and palliative medicine (114) 114
antineoplastic agents - therapeutic use (106) 106
cancer (105) 105
care and treatment (105) 105
hemic and lymphatic diseases (102) 102
myelodysplastic syndrome (100) 100
research (97) 97
survival analysis (91) 91
disease-free survival (90) 90
mutation (88) 88
remission induction (87) 87
risk factors (83) 83
survival rate (83) 83
myelodysplastic syndromes - genetics (80) 80
myelodysplastic syndromes - mortality (76) 76
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (70) 70
leukemia, myeloid, acute - genetics (69) 69
myelodysplastic syndromes - pathology (68) 68
azacitidine - analogs & derivatives (67) 67
follow-up studies (67) 67
chemotherapy (66) 66
imatinib mesylate (64) 64
retrospective studies (62) 62
drug administration schedule (60) 60
leukemia, myeloid, acute - mortality (60) 60
analysis (59) 59
azacitidine - therapeutic use (59) 59
benzamides (56) 56
chronic myeloid leukemia (56) 56
cytarabine - administration & dosage (56) 56
survival (56) 56
myeloid leukemia (54) 54
patients (54) 54
kaplan-meier estimate (53) 53
recurrence (53) 53
dna methylation (52) 52
genetic aspects (51) 51
antineoplastic combined chemotherapy protocols - adverse effects (49) 49
myelodysplastic syndromes - diagnosis (48) 48
pyrimidines - therapeutic use (48) 48
dose-response relationship, drug (47) 47
philadelphia chromosome (46) 46
drug therapy (44) 44
antineoplastic agents - adverse effects (43) 43
cytogenetics (43) 43
leukemia, myeloid, acute - pathology (42) 42
patient outcomes (42) 42
piperazines - therapeutic use (42) 42
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (42) 42
protein kinase inhibitors - therapeutic use (42) 42
stem cells (42) 42
antimetabolites, antineoplastic - therapeutic use (40) 40
decitabine (40) 40
multivariate analysis (40) 40
myelodysplastic syndromes - therapy (40) 40
antineoplastic agents - administration & dosage (39) 39
azacitidine - administration & dosage (39) 39
cytarabine (39) 39
dosage and administration (39) 39
bone marrow - pathology (38) 38
antineoplastic combined chemotherapy protocols - administration & dosage (36) 36
aml (35) 35
bone marrow (35) 35
clinical trials and observations (35) 35
health aspects (35) 35
chromosome aberrations (34) 34
disease progression (33) 33
transplantation (33) 33
azacitidine - adverse effects (30) 30
dna methylation - drug effects (30) 30
leukemia, myeloid, acute - diagnosis (30) 30
mds (30) 30
clinical trials (29) 29
gene expression (29) 29
leukemia, myelogenous, chronic, bcr-abl positive - mortality (29) 29
protein-tyrosine kinases - antagonists & inhibitors (29) 29
tyrosine (29) 29
acute disease (28) 28
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1961) 1961
French (8) 8
German (5) 5
Spanish (2) 2
Chinese (1) 1
Croatian (1) 1
Danish (1) 1
Lithuanian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American journal of hematology, ISSN 0361-8609, 01/2018, Volume 93, Issue 1, pp. 129 - 147
Journal Article
Cancer, ISSN 0008-543X, 05/2017, Volume 123, Issue 6, pp. 994 - 1002
Journal Article
American journal of hematology, ISSN 0361-8609, 07/2012, Volume 87, Issue 7, pp. 692 - 701
Journal Article
British journal of haematology, ISSN 0007-1048, 09/2014, Volume 166, Issue 5, pp. 646 - 659
Summary The myelodysplastic syndromes (MDS) are a group of clonal diseases characterized by inefficient haematopoiesis, increased apoptosis and risk of... 
epigenetics | genetics | myelodysplastic syndromes | Epigenetics | Genetics | Myelodysplastic syndromes | Life Sciences & Biomedicine | Hematology | Science & Technology | Myelodysplastic Syndromes - genetics | Animals | Prognosis | Myelodysplastic Syndromes - pathology | Epigenesis, Genetic | Humans | Epigenetic inheritance | Deregulation | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 02/2017, Volume 376, Issue 8, pp. 796 - 798
To the Editor: Welch et al. (Nov. 24 issue) 1 report the results of a study in which they treated 116 patients, including 26 with myelodysplastic syndromes... 
Myelodysplastic Syndromes | Leukemia, Myeloid, Acute | Remission | Mutation | p53 Protein | Myelodysplastic syndrome | 5-aza-2'-deoxycytidine | Index Medicus | Abridged Index Medicus
Journal Article